The BioNTech SE ADR BNTX inched 0.69% higher to $113.05 Monday, on what proved to be an all-around positive trading session ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a ...

The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated ...

Regulators, policymakers and others can more effectively battle the disease by creating incentives to make mpox a more ...

Novavax uses a protein-based vaccine strategy, which means people getting the vaccine receive a protein made by the virus ...

Assembly Biosciences, Inc. (NASDAQ:ASMB) released interim pharmacokinetic (PK) and safety results from healthy participants ...

The U.S. Food and Drug Administration said households are allowed to order 4 free tests. It says the new tests will detect ...

Health care providers say Iowans should get their COVID-19, influenza and RSV vaccines in September or October ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Terence Flynn, an analyst from Morgan Stanley, has initiated a new Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR). Terence ...

On Aug. 22, the U.S. Food and Drug Administration announced the approval of a new Novavax COVID vaccine, as well as updated ...

Pfizer purchased a stunning amount of radio ads as the company urges getting COVID-19 booster shots and flu vaccinations ...